At a glance
- Originator Pfizer
- Developer Humboldt University; Pfizer; St Vincents Hospital, Sydney
- Class Anti-ischaemics; Antineoplastics; Neuroprotectants
- Mechanism of Action Antioxidants; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury; Septic shock
Most Recent Events
- 04 Sep 2006 Discontinued - Preclinical for Reperfusion injury in USA (unspecified route)
- 04 Sep 2006 Discontinued - Preclinical for Septic shock in Germany (unspecified route)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer